The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia

发表于 2026-8-22 20:53:08

期刊：Therapeutic Advances in Hematology

文献作者：Zixuan Li; Fang Liu; Chun Zhang; Jing He; WeiMing Li; Dairong Xie; Yuting Jiang; Ruofeng Jin; Tianran Gao; Mei Hong; Qiuling Wu

出版日期：2026-7-

DOI号：10.1177/20406207261479931

下载链接：https://journals.sagepub.com/doi/pdf/10.1177/20406207261479931

文献链接：https://doi.org/10.1177/20406207261479931

当前文献来源于 SAGE Publications。

备注信息：

发表于 2026-8-22 20:53:09

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Sage] The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Sage] The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia 一键复制